![]() |
|
|
Vol. 29, Issue 12, 1535-1538, December 2001
Department of Clinical Pharmacology, The Queen Elizabeth Hospital,
Woodville, South Australia (B.C.S., F.L.H.); and Department of Clinical
and Experimental Pharmacology, the University of Adelaide, Adelaide,
South Australia (B.C.S.)
Clinical use of diclofenac is associated with a small but
significant incidence of hepatotoxicity. It has been reported that in
vivo diclofenac treatment results in decreased activity of the
extracellular canalicular membrane protein dipeptidylpeptidase IV in
rats as a consequence of protein adduct formation by its electrophilic
metabolite diclofenac acyl glucuronide. The present study has
investigated the effects of in vivo diclofenac treatment (15 mg/kg/day
for 7 days) on the activity of an another four rat extracellular
canalicular membrane proteins. Animals administered diclofenac
(n = 6) had 47.9, 60.4, and 51.6% lower
(p < 0.05) canalicular activities of
-glutamyltransferase, Mg2+-ATPase, and leucine
aminopeptidase, respectively, compared with controls
(n = 6), but there was no difference in alkaline
phosphatase activity. In general, protein adduct formation by acyl
glucuronides has been associated with decreased protein function, and
the lower canalicular enzyme activities in diclofenac-treated rats may
suggest that
-glutamyltransferase, Mg2+-ATPase, and
leucine aminopeptidase are also targets of adduct formation by acyl
glucuronide metabolites of diclofenac. However, intracellular
redistribution and/or decreased synthesis of these enzymes would also
be consistent with our results. The ability of diclofenac acyl
glucuronide (200 µg/ml) to form covalently bound adducts with
-glutamyltransferase (10 mg/ml) was demonstrated following in vitro
incubations (16 h, pH 7.4, and 37°C) in which 20.7 ± 2.1 ng of
diclofenac were covalently bound per milligram of protein. In these in
vitro studies, the low concentration of protein adducts formed was not
associated with any significant change in
-glutamyltransferase activity.
This article has been cited by other articles:
![]() |
J. R. Kenny, J. L. Maggs, J. N. A. Tettey, A. W. Harrell, S. G. Parker, S. E. Clarke, and B. K. Park FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY Drug Metab. Dispos., February 1, 2005; 33(2): 271 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Grillo, C. G. Knutson, P. E. Sanders, D. J. Waldon, F. Hua, and J. A. Ware STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE Drug Metab. Dispos., November 1, 2003; 31(11): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||